Peter said "...These are exhilarating times for the company; the...

Peter said "...These are exhilarating times for the company; the opportunity to achieve our long term goal - to prove our technology safe and efficacious in humans to both the pharmaceutical industry and regulators - is just around the corner."

Well Peter the trial has clearly come to a holt - the staff you've employed to speed up dosing have not delivered. You have not communicated to the market any additional trial site participation (because there is none) and shareholders are currently guessing.

Your market updates recently on shRNA detection in liver biopsies should have been announced the first time.

The share price has no support, and you are to blame no one else. If you want share holder value for your own holding your not the man for the job.

Resign as CEO and get a US based CEO who has better contacts than you and can list us on an exchange more appropriate to Gene therapy than the ASX.

You will never take Benitec to any sort of Billion dollar market valuation.